6Camera A, Hopps E. Caimi G. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects [J]. Minerva Endocrinol ,2007, 32(3):209-229.
7Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes ,2005, 54(6) : 1615-1625.
8Casellini CM, Vinik AI. Clinical manifestationa and current treatment options for diabetic neuropathies [ J ]. Endocr Pract, 2007,13(5) : 550-566.
9Ho EC. Aldose reductase-deficient mice are prolected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage [J]. Diabetes ,2006,55(7) : 1946-1953.
10Oates PJ. Aldose reductase, still a compelling larger for diabetie neuropathy[J]. Curr Drug Targets ,2008, 9(1) : 14.
